Dr. Eads is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Fl 3
Philadelphia, PA 19104Phone+1 215-615-5858Fax+1 215-615-3349
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2005 - 2009
- Tufts University School of MedicineClass of 2005
Certifications & Licensure
- PA State Medical License 2018 - 2024
- OH State Medical License 2005 - 2019
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors Start of enrollment: 2007 Aug 16
- Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction Start of enrollment: 2013 Aug 23
- Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer Start of enrollment: 2018 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsPrediction ofLu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation onGa-DOTATATE PET/CT.Hwan Lee, Sarit T Kipnis, Remy Niman, Sophia R O'Brien, Jennifer R Eads
Cancers. 2023-12-31 - 1 citationsResponse to Letter to Editor re: "Combined Quantification of 18F-FDG and 68Ga-DOTATATE PET/CT for Prognosis in High-Grade Gastroenteropancreatic Neuroendocrine Neoplas...Hwan Lee, Ryusuke Nakamoto, Stephen E Moore, Austin R Pantel, Jennifer R Eads
Academic Radiology. 2022-09-01 - 1 citationsIs it Time Yet for Adjuvant Immunotherapy for Patients with DNA Mismatch Repair Deficient Gastric Cancer?Jennifer R Eads
Annals of Surgical Oncology. 2022-04-01
Press Mentions
- Leap Therapeutics Presents Positive DKN-01 Clinical Data in Biliary Tract Cancers at American Society of Clinical Oncology (ASCO) 2017 Annual MeetingMay 17th, 2017
- Neuroendocrine Tumor Treatment Options Are GrowingMarch 25th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: